Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
Longer mean duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment seen with dostarlimab
4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone
Dapagliflozin Beneficial for Improving MASH Without Worsening Fibrosis
Dapagliflozin results in more patients with improved or resolved MASH without worsening of fibrosis, improved fibrosis without worsening of MASH
GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes
More than twofold increased risk seen for nAMD development in unadjusted and adjusted models
Long-Lasting HIV Prevention Shot Headed Toward Approval
ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
Better event-free survival outcomes seen for durvalumab plus FLOT versus FLOT alone in phase 3 randomized trial
RFK Jr. Calls for a Review of Abortion Pill Mifepristone
Widespread Decline Seen in MMR Vaccination Rates After COVID-19
Seventy-eight percent of 2,066 U.S. counties reported decline in coverage from prepandemic to postpandemic
Initiation of HIV PrEP in Young Adults Rose in Recent Years
PrEP dispensing and initiation have increased but PrEP persistence has decreased
ASCO: Elinzanetant Cuts Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer
